(100ca021)Development of New Anti-Cancer Indications for Protein Drug Candidate of αvβ3 Antagonist-PEG-ARLDDL (III)

2013-05-012024-05-13https://scholars.lib.ntu.edu.tw/handle/123456789/643544(100ca021)Development of New Anti-Cancer Indications for Protein Drug Candidate of αvβ3 Antagonist-PEG-ARLDDL (III)